BioXcel Therapeutics (BTAI) Operating Expenses (2017 - 2026)
BioXcel Therapeutics (BTAI) posted quarterly Operating Expenses of $10.4 million for Q1 2026, up 1.58% year-over-year from $10.3 million in Q1 2025, and down 1.03% quarter-over-quarter from $10.5 million in Q4 2025.
BioXcel Therapeutics (BTAI) Operating Expenses (2017 - 2026) Analysis & Trends
BioXcel Therapeutics' Operating Expenses history runs 10 years deep, the most recent figure standing at $10.4 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 1.58% year-over-year to $10.4 million; the TTM figure through Mar 2026 stood at $51.3 million (down 6.85% YoY), while the FY2025 annual figure was $51.1 million, down 26.48% from the prior year.
- Operating Expenses for Q1 2026 stood at $10.4 million, down from $10.5 million in the prior quarter.
- The five-year high for Operating Expenses was $53.1 million in Q4 2022, with the low at $10.3 million in Q1 2025.
- The 5-year median for Operating Expenses is $20.3 million (2023), against an average of $27.3 million.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses jumped 103.33% in 2022, then sank 68.12% in 2024.
- BioXcel Therapeutics' Operating Expenses stood at $53.1 million in 2022, then tumbled by 61.89% to $20.3 million in 2023, then plunged by 46.38% to $10.9 million in 2024, then dropped by 2.96% to $10.5 million in 2025, then slipped by 1.03% to $10.4 million in 2026.
- Business Quant data shows BTAI's Operating Expenses at $10.4 million in Q1 2026, $10.5 million in Q4 2025, and $14.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | BioXcel Therapeutics | 24.95 Mn | 24.95 Mn | 160,000.00 | 10.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.38 Mn |
| Mar 31, 2026 | 10.43 Mn |
| Dec 31, 2025 | 10.54 Mn |
| Sep 30, 2025 | 14.33 Mn |
| Jun 30, 2025 | 15.97 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Dec 31, 2024 | 10.86 Mn |
| Sep 30, 2024 | 15.51 Mn |
| Jun 30, 2024 | 18.40 Mn |
| Mar 31, 2024 | 24.75 Mn |
| Dec 31, 2023 | 20.25 Mn |
| Sep 30, 2023 | 48.64 Mn |
| Jun 30, 2023 | 52.87 Mn |
| Mar 31, 2023 | 51.40 Mn |
| Dec 31, 2022 | 53.13 Mn |
| Sep 30, 2022 | 39.13 Mn |
| Jun 30, 2022 | 36.29 Mn |
| Mar 31, 2022 | 31.48 Mn |
| Dec 31, 2021 | 26.13 Mn |
| Sep 30, 2021 | 26.81 Mn |